Skip to content
drillr.ai
Sign up

GANX

Gain Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.80
−1.10%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue———55.2K140.1K
Cost of Revenue—————
Gross Profit———55.2K140.1K
Operating Expenses
R&D Expense10.1M10.2M10.8M11.5M8.4M
SG&A Expense9.2M8.5M9.6M10.8M9.5M
General & Admin Expense9.2M8.5M9.6M10.8M9.5M
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses19.3M18.7M20.4M22.3M17.9M
Cost and Expenses19.3M18.7M20.4M22.3M17.9M
Operating Income (EBIT)(19.3M)(18.7M)(20.4M)(22.3M)(17.8M)
Non-Operating
Interest Income315.5K244.4K357.1K494.2K375.4K
Interest Expense—————
Net Interest Income315.5K244.4K357.1K494.2K375.4K
Other Non-Op Income/Expense87.3K(589.3K)476.2K64.9K279.3K
Non-Operating Income (excl Interest)(87.3K)589.3K(476.2K)(64.9K)(279.3K)
EBT (Pre-Tax Income)(19.2M)(19.3M)(19.9M)(22.2M)(17.5M)
Income Tax Expense906.5K861.1K536.8K79.3K93.0K
Bottom Line
Net Income(20.1M)(20.2M)(20.4M)(22.3M)(17.6M)
Earnings from Cont. Ops(20.1M)(20.2M)(20.4M)(22.3M)(17.6M)
Earnings from Discont. Ops—————
Bottom Line Net Income(20.1M)(20.2M)(20.4M)(22.3M)(17.6M)
Per Share
Basic EPS($0.50)($0.61)($0.89)($1.71)($1.48)
Diluted EPS($0.50)($0.61)($0.89)($1.71)($1.48)
Revenue Per Share$0.00$0.00$0.00$0.00$0.01
Shares
Basic Shares Outstanding42.9M33.0M22.9M13.0M11.9M
Diluted Shares Outstanding42.9M33.0M22.9M13.0M11.9M
Profitability Metrics
EBITDA(19.1M)(19.2M)(19.8M)(22.1M)(17.4M)
D&A99.5K94.0K84.1K83.6K64.2K
EBIT(19.2M)(19.3M)(19.9M)(22.2M)(17.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026